News

Del’s new headquarters, a 22,000 square foot facility in the Turnberry Lakes Technology Park will feature a digital showroom that will be used as a walk-through showcase of

Small Bone Innovations has received an approvable letter from the FDA for the Scandinavian Total Ankle Replacement system. The approvable letter states that the FDA has concluded its

Emergent BioSolutions, a developer and marketer of immunobiotics, has reported net income of $1.5m, or $0.05 diluted earnings per share for the fourth quarter of 2008, compared to

Biolase Technology, a dental laser company, has renewed and expanded its multi-year licensing and distribution agreement with Henry Schein, a provider of healthcare products and services to office-based

For the year ended December 31, 2008, Acadia reported a net loss of $64.2 million, or $1.73 per share, compared to a net loss of $56.4 million, or

Endo Pharmaceuticals, a specialty pharmaceutical company, has licensed the exclusive rights to develop and market the investigational drug axomadol in the US and Canada from the German pharmaceutical

The net loss in the fourth quarter of 2008 as compared to the net income in the fourth quarter of 2007 was due to an increase in operating

The company reported a net loss of $6.65 million, or $0.21 per share, for the year ended December 31, 2008, compared to a net loss of $6.22 million,

Net loss for the year ended December 31, 2008 was $47 million, or $0.56 per diluted share, compared to a net loss of $99.3 million, or $1.39 per